Latest News

AI discontinuation common among breast cancer patients

AI discontinuation common among breast cancer patients

Nearly a third of early-stage breast cancer patients stop their aromatase inhibitor treatment early because of intolerance, although when offered an alternative AI medication, over a third are able to continue.

0

Patients want greater role in breast cancer treatment

Patients want greater role in breast cancer treatment

Two-thirds of women with early-stage breast cancer want to be involved in planning their treatment, although just under half say their doctor ultimately made the decision, an Australian-funded study reports.

0

view more

Clinical News

PSA values identify candidates for long-term ADT

PSA values identify candidates for long-term ADT

Prostate-specific antigen values can act as an early surrogate for prostate cancer-specific mortality, identifying patients most likely to benefit from long-term androgen suppression therapy, researchers say.

0

New evidence backs expansion of bowel cancer screening

New evidence backs expansion of bowel cancer screening

Cancer experts say new evidence backs the already persuasive case to extend bowel cancer screening program from one off tests to biennial screening.

0

view more

Features

view more

Politics

No green light for food labelling

No green light for food labelling

The AMA has accused the Government of caving in to the food industry after failing to endorse traffic light labelling for foods.

0

Quack remedies need tighter regulation

The TGA’s "light touch" approach to regulating alternative therapies has been a failure, with an audit finding high levels of false claims under the system based on self regulation.

0

view more

Other News

One liaison psychiatrist needed per 100 beds

One liaison psychiatrist needed per 100 beds

Hospitals need a minimum of about one full-time consultation-liaison psychiatrist per 100 beds, but more are needed if they are expected to do any research.

0

Jury still out on NSAIDs role in cancer prevention

Jury still out on NSAIDs role in cancer prevention

The debate on whether NSAIDs have a chemopreventive role to play has resurfaced this week, with the latest analysis finding users of aspirin have a significantly reduced risk for oesophageal cancers.

0

view more

Jobs

view more
to get Oncology Update delivered to your inbox

Browse our newsletter archive

Advertisement

Oncology Update on Twitter

­